Holdings of Stonepine Capital Management, LLC
55 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 69.9 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 97.5 %
- AU 2.5 %
- DK 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 53 | 102.1M $ | 97.48 % |
| 2 | AU | 1 | 2.6M $ | 2.45 % |
| 3 | DK | 1 | 73.3K $ | 0.07 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Verastem Inc | 3,302,300 | 17.5M $ | |
| 2 | Tenax Therapeutics Inc | 975,200 | 15.6M $ | |
| 3 | Evolus Inc | 1,759,091 | 7.2M $ | |
| 4 | ADMA Biologics Inc | 740,000 | 6.7M $ | |
| 5 | CAMP4 THERAPEUTICS CORP | 1,389,622 | 6.1M $ | |
| 6 | Nektar Therapeutics | 85,000 | 6.1M $ | |
| 7 | Zevra Therapeutics Inc | 480,000 | 4.5M $ | |
| 8 | Corbus Pharmaceuticals Holdings Inc | 383,462 | 3.6M $ | |
| 9 | Abeona Therapeutics Inc | 746,587 | 3.3M $ | |
| 10 | KAZIA THERAPEUTICS LTD | 345,179 | 2.6M $ | |
| 11 | AN2 Therapeutics Inc | 713,845 | 2.4M $ | |
| 12 | XOMA Royalty Corp | 69,500 | 2.2M $ | |
| 13 | Aytu BioPharma Inc | 792,289 | 2.2M $ | |
| 14 | CURIS INC | 3,726,406 | 2M $ | |
| 15 | TELA BIO INC | 2,617,252 | 1.6M $ | |
| 16 | Inhibikase Therapeutics Inc | 957,202 | 1.6M $ | |
| 17 | Adicet Bio Inc | 221,955 | 1.5M $ | |
| 18 | X4 PHARMACEUTICALS INC | 335,309 | 1.4M $ | |
| 19 | Heron Therapeutics Inc | 1,402,191 | 1.1M $ | |
| 20 | Pulmonx Corp | 768,288 | 991.1K $ | |
| 21 | IN8BIO INC | 663,412 | 981.9K $ | |
| 22 | Surrozen Inc | 33,005 | 961.4K $ | |
| 23 | CytomX Therapeutics Inc | 200,000 | 940K $ | |
| 24 | PMV Pharmaceuticals Inc | 708,102 | 878K $ | |
| 25 | BioAge Labs Inc | 50,000 | 874.5K $ | |
| 26 | MaxCyte Inc | 1,004,673 | 705.8K $ | |
| 27 | Codexis Inc | 417,994 | 681.3K $ | |
| 28 | BOUNDLESS BIO INC | 597,682 | 657.5K $ | |
| 29 | Zentalis Pharmaceuticals Inc | 269,100 | 629.7K $ | |
| 30 | PASITHEA THERAPEUTICS CORP | 831,301 | 616.7K $ | |
| 31 | Phathom Pharmaceuticals Inc | 50,010 | 555.6K $ | |
| 32 | OnKure Therapeutics Inc | 132,578 | 548.9K $ | |
| 33 | Xilio Therapeutics Inc | 64,162 | 539.6K $ | |
| 34 | Verrica Pharmaceuticals Inc | 99,735 | 527.6K $ | |
| 35 | Candel Therapeutics Inc | 102,500 | 502.3K $ | |
| 36 | PRECISION OPTICS INC MASS | 100,000 | 439K $ | |
| 37 | Upstream Bio Inc | 35,000 | 315K $ | |
| 38 | Opus Genetics Inc | 68,688 | 312.5K $ | |
| 39 | Arvinas Inc | 27,500 | 291.5K $ | |
| 40 | Pliant Therapeutics Inc | 224,650 | 283.1K $ | |
| 41 | Janux Therapeutics Inc | 20,000 | 278K $ | |
| 42 | OmniAb Inc | 164,045 | 257.6K $ | |
| 43 | Xeris Biopharma Holdings Inc | 40,030 | 232.2K $ | |
| 44 | Neumora Therapeutics Inc | 100,000 | 195K $ | |
| 45 | SAB Biotherapeutics Inc | 50,000 | 191.5K $ | |
| 46 | SI-BONE Inc | 14,964 | 189K $ | |
| 47 | CNS PHARMACEUTICALS INC | 61,000 | 145.8K $ | |
| 48 | PROCESSA PHARMACEUTICALS INC | 55,000 | 138.9K $ | |
| 49 | Cabaletta Bio Inc | 50,000 | 134.5K $ | |
| 50 | KALARIS THERAPEUTICS INC | 20,400 | 117.7K $ | |
| 51 | Eledon Pharmaceuticals Inc | 35,000 | 107.8K $ | |
| 52 | Ovid therapeutics Inc | 40,000 | 88.8K $ | |
| 53 | EVAXION A/S | 19,713 | 73.3K $ | |
| 54 | MannKind Corp | 16,300 | 39.9K $ | |
| 55 | BIOATLA INC | 65,387 | 10.5K $ | |